CADASIL syndrome is the most common inherited form of small vessel disease in the brain, caused by mutations in the NOTCH3 gene that gradually damage the walls of small blood vessels supplying deep brain tissue. The name itself is an acronym: Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. In plainer terms, it is a genetic condition passed from parent to child that leads to recurrent small strokes, progressive white matter damage, and, for many people, eventual cognitive decline. Because it unfolds over decades and its early symptoms overlap with common conditions, CADASIL is often misdiagnosed or recognized only after years of unexplained neurological problems.
What Goes Wrong in the Blood Vessels
CADASIL traces back to mutations in the NOTCH3 gene, which provides instructions for a receptor protein found on smooth muscle cells lining small arteries. The disease-causing mutations always affect specific cysteine residues in the protein’s outer domain, disrupting the normal number of cysteine pairs and altering how the protein folds and behaves at the cell surface.1Human Molecular Genetics. CADASIL mutations enhance spontaneous multimerization of NOTCH3 What happens next is a slow accumulation of abnormal NOTCH3 protein fragments on and around those smooth muscle cells. Over time, these cells degenerate, the vessel walls weaken, and the arteries lose their ability to respond properly to changes in blood flow.
One of the signature findings under an electron microscope is a material called granular osmiophilic material, or GOM, which builds up in the basement membrane surrounding the affected cells. In animal models, these GOM deposits start small and barely detectable, then grow larger and denser with age.2PubMed Central. Progression and Classification of Granular Osmiophilic Material (GOM) Deposits in Functionally Characterized Human NOTCH3 Transgenic Mice In human tissue, the damage is visible as marked destruction of smooth muscle cells, thinning of vessel walls, and loss of the structural material that normally holds blood vessels together, rather than the narrowing you might expect with typical vascular disease.3PubMed. Morphometric analysis of ultrastructural vascular changes in CADASIL: analysis of 50 skin biopsy specimens and pathogenic implications
The practical result is that these weakened vessels can no longer regulate blood flow the way healthy vessels do. Studies using transcranial Doppler have shown that people with CADASIL have reduced ability to adjust cerebral blood flow in response to carbon dioxide, a sign that the smooth muscle cells can no longer contract and relax normally.4PubMed. Reduced cerebrovascular CO(2) reactivity in CADASIL: A transcranial Doppler sonography study Impaired coupling between neural activity and blood flow has also been detected early in the disease, before major symptoms appear.5PubMed Central. Altered dynamics of neurovascular coupling in CADASIL The brain’s smallest arteries become progressively unable to deliver the right amount of blood at the right time, setting the stage for everything that follows.
Migraine With Aura as the First Warning
For many people with CADASIL, the first symptom is migraine with aura, and it often starts years or even decades before anyone suspects an underlying vascular disease. Roughly half of all individuals carrying a NOTCH3 mutation report a history of migraine, and among those with migraine, about 84% experience the aura subtype, which involves visual disturbances, sensory changes, or difficulty with speech before the headache sets in.6PubMed. Prevalence and characteristics of migraine in CADASIL Migraine with aura was the very first symptom in about 41% of symptomatic patients in the same study. The proportion of migraine with aura in CADASIL is much higher than in the general population, where migraine with aura makes up a smaller fraction of all migraine cases.7PubMed. CADASIL and migraine: A narrative review
This is one of the reasons CADASIL flies under the radar for so long. Migraine is extremely common in the general population, and even the aura subtype affects millions of people who have no genetic vessel disease. A young person in their twenties or thirties with migraine with aura is unlikely to be evaluated for CADASIL unless there is a known family history of stroke or dementia. For about 12% of individuals with the mutation, migraine with aura remains the only symptom they experience.8PubMed. Prevalence and characteristics of migraine in CADASIL But for most, it is only the opening act.
Strokes and White Matter Damage
CADASIL is characterized by recurrent small strokes, typically in the deep structures of the brain, which accumulate over time alongside progressive white matter degeneration.9PubMed Central. CADASIL: experimental insights from animal models These are not the large, sudden strokes caused by a blood clot blocking a major artery. Instead, they are lacunar infarcts, tiny areas of dead tissue deep inside the brain. Each individual event may cause relatively subtle symptoms: a brief episode of weakness, numbness, or speech difficulty. But each one leaves a permanent scar, and the damage adds up.
On brain MRI, the accumulating damage is often striking. People with CADASIL develop extensive white matter hyperintensities, which appear as bright patches on certain MRI sequences. These areas represent damaged and demyelinated tissue. The pattern of involvement can help distinguish CADASIL from other causes of white matter disease. Hyperintensities in the anterior temporal lobe are particularly characteristic: one study found that white matter changes confined to the temporal pole appeared in CADASIL patients but in none of the comparison patients with ordinary age-related white matter disease.10PubMed. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL Involvement of a structure called the external capsule is also common, often visible early in the disease. Additional MRI findings include multiple lacunes, cerebral microbleeds, and enlarged perivascular spaces.11PubMed. Dilated perivascular spaces in small-vessel disease: a study in CADASIL Pericyte dysfunction may help explain why the perivascular spaces dilate and why white matter lesions develop in the patterns they do.12Cerebral Circulation – Cognition and Behavior. The pericyte: A critical cell in the pathogenesis of CADASIL
Cognitive Decline and Dementia
As strokes and white matter injury accumulate, cognition deteriorates. The earliest changes tend to affect executive functions: planning, organizing, mental flexibility, and the ability to shift between tasks. At this stage, memory and language often remain relatively intact, which can mask the severity of what is happening. A person may seem a bit slower or more distractible, but does not appear “demented” in the way people typically imagine.13Journal of Neurology, Neurosurgery & Psychiatry. Cognitive profile in CADASIL
Over time, the cognitive impairment broadens. Skills in other domains begin to deteriorate, and what started as subtle executive slowness eventually progresses, in many cases, to a full dementia syndrome involving memory, attention, and other areas.14International Psychogeriatrics. Cognitive Syndrome(s) in Preclinical and Clinical Vascular Dementia The transition from mild executive dysfunction to broader dementia can take many years, but the trajectory tends to move in one direction. By the time formal dementia criteria are met, the damage on MRI is usually extensive.
Mood and Psychiatric Symptoms
Depression and other mood disturbances are reported in roughly 10% to 20% of CADASIL patients in cross-sectional studies, often alongside cognitive changes.15PubMed Central. Neuropsychiatric manifestations in CADASIL But those estimates may undercount the problem. A smaller study using structured psychiatric interviews found that nearly three-quarters of the CADASIL patients assessed had experienced a depressive episode at some point in their lives, and about a quarter were experiencing active depression at the time of evaluation.16PubMed. Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview
The cause is likely a mix of factors. Ischemic lesions in certain brain regions, particularly the basal ganglia and frontal white matter, may directly disrupt the circuits that regulate mood.17PubMed Central. Neuropsychiatric manifestations in CADASIL But the psychological burden of living with a progressive, hereditary neurological disease also plays a role. Emotional disturbances have been linked to lower quality of life for patients and greater burden for their caregivers.18PubMed. Emotional disturbance in CADASIL: its impact on quality of life and caregiver burden These psychiatric symptoms deserve treatment in their own right and should not be dismissed as an inevitable part of the disease.
Why CADASIL Gets Mistaken for Multiple Sclerosis
One of the more consequential diagnostic pitfalls is the confusion between CADASIL and multiple sclerosis. Both conditions can produce white matter lesions on MRI, both can present in young or middle-aged adults, and both can cause episodic neurological symptoms. Case reports describe patients who were diagnosed with MS and treated with disease-modifying therapies for years before someone ordered genetic testing and found a NOTCH3 mutation.19PubMed Central. CADASIL vs. Multiple Sclerosis: Is It Misdiagnosis or Concomitant? A Case Series In one case series, a patient received MS treatment for about 15 years with no improvement before the correct diagnosis was made.
The consequences of misdiagnosis are real. MS treatments suppress the immune system to reduce inflammatory attacks on the nervous system. In CADASIL, the damage is vascular, not inflammatory, so these drugs offer no benefit and carry unnecessary risk. Several clues can help distinguish the two. The temporal pole white matter hyperintensities characteristic of CADASIL are unusual in MS. A family history of stroke or early dementia should also raise suspicion. When white matter lesions on MRI do not quite fit the classic MS pattern, or when the patient does not respond to MS-directed therapy, genetic testing for CADASIL is warranted.20PubMed. CADASIL as Multiple Sclerosis Mimic: A 48-year-old man with severe leukoencephalopathy and spinal cord involvement Regional differences in where white matter lesions appear within the brain can also help differentiate CADASIL from other small vessel diseases.21PubMed Central. Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain
How CADASIL Is Diagnosed
The gold standard for diagnosing CADASIL is genetic testing to identify a mutation in the NOTCH3 gene. This can be done with a simple blood draw. Before genetic testing became widely available, diagnosis sometimes relied on skin biopsy, where a small sample of skin would be examined under an electron microscope for the presence of GOM deposits in the walls of small arteries. The GOM deposits are not confined to the brain; they also appear in blood vessels throughout the body, including the skin, which made biopsy a useful shortcut. Skin biopsy is still performed occasionally, but direct DNA testing is now the preferred approach because it is more definitive and less invasive.22PubMed. Differential diagnosis of a vascular leukoencephalopathy within a CADASIL family: use of skin biopsy electron microscopy study and direct genotypic screening
Brain MRI plays a supporting role. While it cannot confirm the diagnosis by itself, certain MRI patterns can strongly suggest CADASIL and prompt genetic testing. The American Heart Association has issued a scientific statement reviewing the clinical, genetic, and imaging features of CADASIL and contrasting it with other inherited small vessel diseases, aiming to reduce the kind of diagnostic variability that leads to years-long delays.23PubMed. Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association
Researchers are also exploring blood-based biomarkers that could track disease severity without repeated imaging. Serum neurofilament light chain, a protein released when nerve fibers are damaged, has shown promise. In one study, serum neurofilament light levels correlated with the number of lacunes, the degree of brain atrophy, cognitive scores, and disability level at baseline. Even more strikingly, baseline levels predicted changes in disability and cognition over the following seven years, and were associated with survival over 17 years of follow-up.24PubMed Central. Serum Neurofilament light correlates with CADASIL disease severity and survival If validated in larger studies, a simple blood test could help clinicians monitor disease progression and eventually gauge whether future treatments are working.
Disease Trajectory and Prognosis
CADASIL is progressive, but its pace varies widely among individuals and even within families carrying the same mutation. A large retrospective study of 411 patients mapped out the typical milestones. The median age at which men needed help walking was about 59, and for women it was about 62. Becoming bedridden happened at a median age of about 62 for men and 67 for women. Median age at death was roughly 65 for men and 71 for women, and the difference between sexes was significant: male sex was a clear risk factor for earlier immobilization and death.25PubMed. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients
By the time of death, about 78% of patients in that study were completely dependent, and 63% were bedridden. The most frequent cause of death was pneumonia, accounting for about 38% of cases, followed by sudden unexpected death at 26% and asphyxia at 12%. Certain specific NOTCH3 mutations were associated with earlier death or earlier onset of stroke and immobilization, suggesting that the exact location of the mutation within the gene makes a difference.26PubMed. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients Modifiable factors matter too: hypertension and smoking have been associated with earlier onset of stroke in CADASIL.27PubMed Central. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) presenting with stroke in a young man
Treatment and Management
There is no cure for CADASIL, and no drug has been proven to slow or stop its progression. Management is largely about controlling vascular risk factors and treating symptoms as they arise. Blood pressure control and smoking cessation are emphasized, given their association with earlier stroke onset. Migraine can be treated with standard preventive and acute therapies, though some clinicians avoid triptans out of concern about their vasoconstrictive effects in patients with underlying vessel disease.
Whether to use antiplatelet drugs like aspirin is a persistent question. In ordinary stroke prevention, antiplatelets are a mainstay. In CADASIL, the calculus is less clear because the vessel walls are inherently fragile and the risk of bleeding into the brain (intracerebral hemorrhage) may be elevated. A retrospective analysis found that antiplatelet use did not significantly change the likelihood of ischemic stroke in CADASIL patients, and rates of intracerebral hemorrhage were similar between those who used antiplatelets and those who did not, though the study was too small to draw firm conclusions about hemorrhage risk specifically.28PubMed. Antiplatelet use and CADASIL: a retrospective observational analysis In practice, the decision tends to be individualized, weighed against each patient’s stroke history and bleeding risk.
Research Into Future Therapies
Since the fundamental problem in CADASIL is the accumulation of mutant NOTCH3 protein around blood vessels, researchers have been exploring whether it might be possible to clear that protein or prevent it from building up. One approach that has generated interest is immunotherapy. In a mouse model of CADASIL, repeated immunization with a short peptide derived from the mutated NOTCH3 protein led to reduced NOTCH3 deposits around brain capillaries and lower levels of NOTCH3 protein fragments in the blood.29PubMed Central. Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model This is still far from human application, but it represents one of the first demonstrations that the protein buildup can be reduced with a targeted intervention.
Mouse models have been critical for understanding the disease, even though they do not perfectly replicate the human condition. Transgenic mice expressing mutant NOTCH3 develop the hallmark GOM deposits and NOTCH3 accumulation in their arteries, but the severe brain tissue damage seen in human patients has been harder to reproduce in mice.30PubMed Central. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy That gap between the vascular changes and the brain damage in animal models has itself been informative. It suggests that smooth muscle cell degeneration may not be driven solely by the protein accumulation, but may also involve disruption of how those cells anchor to their surroundings. Understanding those intermediate steps could open up additional therapeutic targets.
Genetic Counseling and Family Planning
Because CADASIL follows autosomal dominant inheritance, each child of an affected parent has a 50% chance of inheriting the mutation. The disease is highly penetrant, meaning that people who carry the mutation will almost always develop symptoms at some point during their lives, though the timing and severity vary. This creates difficult decisions for families, especially for younger members who may be asymptomatic but at risk.
Predictive genetic testing is available for at-risk family members who want to know their status before symptoms develop. This is a deeply personal choice. Some people want the information so they can plan their careers, finances, and families. Others prefer not to know, since there is currently no treatment that changes the disease course. Genetic counseling before and after testing is considered essential to help individuals process the implications.
For couples where one partner carries a NOTCH3 mutation and who want to avoid passing it to their children, preimplantation genetic diagnosis has been successfully used. This involves testing embryos created through in vitro fertilization and implanting only those without the mutation. Given the dominant inheritance, high penetrance, and serious consequences of CADASIL, this reproductive option is recognized as a reasonable consideration following proper genetic counseling.31PubMed. Pregnancy following preimplantation genetic diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Living With CADASIL and Caregiver Burden
The slow, progressive nature of CADASIL means that the burden extends well beyond the patient. As cognitive abilities decline and physical dependence increases, caregivers take on escalating responsibilities. Research has found that emotional disturbances in patients, including depression, apathy, and irritability, are among the strongest drivers of reduced quality of life for the patient and increased burden for the caregiver.32PubMed. Emotional disturbance in CADASIL: its impact on quality of life and caregiver burden These emotional changes were associated with microbleeds in specific brain regions, which supports the idea that at least part of the mood disruption is a direct consequence of brain injury rather than a purely psychological reaction to the diagnosis.
Support networks, caregiver respite programs, and early involvement of palliative care teams can make a meaningful difference in the quality of life for both patients and their families. Because CADASIL is rare, many people feel isolated after diagnosis. Patient advocacy groups and online communities have become important resources for sharing practical strategies, connecting families, and pushing for more research funding. The disease’s relative obscurity, even among neurologists, means that patients and their families often become their own best advocates.